Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table 10 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner
  1. Home
  2. Publications
  3. Supplementary Table 10 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner

Supplementary Table 10 from EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell–Dependent Manner

Authors:
  • LNLily L. Nguyen
    Lily L. Nguyen
  • ZWZachary L. Watson
    Zachary L. Watson
  • RORaquel Ortega
    Raquel Ortega
  • EWElizabeth R. Woodruff
    Elizabeth R. Woodruff
  • KJKimberly R. Jordan
    Kimberly R. Jordan
  • RIRitsuko Iwanaga
    Ritsuko Iwanaga
  • TYTomomi M. Yamamoto
    Tomomi M. Yamamoto
  • CBCourtney A. Bailey
    Courtney A. Bailey
  • FTFrancis To
    Francis To
  • SLShujian Lin
    Shujian Lin
  • FVFabian R. Villagomez
    Fabian R. Villagomez
  • AJAbigail D. Jeong
    Abigail D. Jeong

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1541-7786.32714257
Abstract
Hallmark pathways negatively enriched in ID8-R cells treated with combinatory UNC0642/Olaparib compared to Olaparib alone.
Keywords
  • DRUG RESISTANCE
  • EPIGENETICS
  • EPIGENOMICS
  • HISTONE MODIFICATION
  • GYNECOLOGICAL CANCERS
  • OVARIAN CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.